Vanguard Portfolio Management’s Cabaletta Bio CABA Stock Holding History

Vanguard Portfolio Management’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.41M	Buy	+1,418,108	New	+$4.66M	﹤0.01%	2479

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Portfolio Management's CABA Position: Q2 2026 in Review

Vanguard Portfolio Management opened a new position in Cabaletta Bio (CABA) in Q2 2026: 1,418,108 shares worth $4.41M. The stake represents ﹤0.01% of the portfolio and ranks #2479 among its holdings.

86 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

Vanguard Portfolio Management held 1,418,108 shares of Cabaletta Bio worth $4.41M as of Q2 2026.
Cabaletta Bio was a new Vanguard Portfolio Management position in Q2 2026.
Cabaletta Bio made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2479 holding.
86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.